ClinicalTrialsFinder

Non-small Cell Lung Cancer Recurrent Clinical Trials in Canton, Ohio

1 recruitingCanton, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 2

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Non-small Cell Lung CancerMetastatic Squamous Non-Small Cell Lung CarcinomaNon-Small Cell Lung Cancer (Stage III)+5 more
Genelux Corporation142 enrolled16 locationsNCT06463665